	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S84-PMC2290997	PMC2290997	4/2008	S84-PMC2290997	['People living at higher latitudes throughout the world are at higher RISK of hypertension, and patients with Cardiovascular disease are OFTEN found to be deficient in Vitamin D, ACCORDING TO research by harvard medical school professor thomas j. wang and colleagues in the 29 january 2008 issue of circulation .']	[('IMPORTANT_CONSIDERATION', 69), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 178)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'People'), ('UBERON_0004535', 'cardiovascular system', 109, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
S14-PMC2582131	PMC2582131	11/2008	S14-PMC2582131	['HOWEVER, the ubiquitous distribution of Intracellular Vitamin D Receptor across diverse Tissues[1]and the EMERGING epidemiological EVIDENCE DOCUMENTING INCREASED RISKS of hypertension[2],[3], Cardiovascular disease[4]–[7], and selected cancers[1],[8]ASSOCIATED with Vitamin D deficiency underscore the pleiotropic actions of Vitamin D. evidence is also accumulating for a ROLE of Vitamin D in maintaining normal Glucose Homeostasis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 372)]	6	[('GO_0005622', 'intracellular anatomical structure', 40, 'intracellular'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 54, 'vitamin D receptor'), ('UBERON_0000479', 'tissue', 88, 'tissues'), ('UBERON_0004535', 'cardiovascular system', 192, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_17234', 'glucose', 412, 'glucose'), ('GO_0042593', 'glucose homeostasis', 412, 'glucose homeostasis')]
S18-PMC2798111	PMC2798111	12/2010	S18-PMC2798111	"[""furthermore, Vitamin D deficiency HAS BEEN ASSOCIATED with a NUMBER OF disease states including but certainly not limited to rheumatoid arthritis [10], multiple sclerosis [11–14], type i and ii diabetes [15–19], crohn's disease [20], Cardiovascular disease [21,22], and a NUMBER of cancers [23,24].""]"	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 272)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 234, 'cardiovascular')]
S34-PMC2821652	PMC2821652	2/2010	S34-PMC2821652	['WHILE rickets HAS BEEN traditionally THOUGHT TO be the main sequelae of Vitamin D deficiency, numerous OTHER long-latency disease states (such as multiple sclerosis [23–25], rheumatoid arthritis [26–29], type 1 and 2 diabetes [30–34], Cardiovascular disease [35,36], various cancers [37–43], and systemic lupus erythematosus [44], to name BUT a few) as well as acute infections such as Upper Respiratory illnesses [45] and tuberculosis [46,47] are now LINKED with Vitamin D deficiency that are EXPLAINED by alterations in Immune function [47–49].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 339), ('SUPERFICIAL_RELATIONSHIP', 452), ('PROBABLE_UNDERSTANDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 235, 'cardiovascular'), ('UBERON_0001154', 'vermiform appendix', 386, 'upper respiratory'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0002405', 'immune system', 522, 'immune')]
S128-PMC2873552	PMC2873552	4/2010	S128-PMC2873552	"[""caption (table-wrap): table 2\n\nfunctions and diseases related to both ceu and yri Signaturesceuyri diabetes 1.70e-172.70e-20 Coronary Artery disease 3.78e-173.12e-13 Genetic disorder 1.09e-144.53e-14 Cardiovascular disease 1.34e-144.78e-11 non-Insulin-dependent diabetes mellitus 1.03e-128.66e-15 Endocrine System disorder 1.91e-121.25e-18 hypertension 2.13e-122.83e-11 Neurological disorder 2.49e-123.27e-12 crohn's disease 7.59e-127.25e-09 bipolar affective disease 3.50e-115.24e-09 Metabolic disorder 5.66e-119.83e-16 inflammatory disorder 2.56e-091.08e-08 Digestive System disorder 2.66e-091.31e-07 Skeletal and muscular disorder 1.49e-081.58e-08 progressive motor neuropathy 2.53e-085.59e-12 Autoimmune disease 7.28e-081.09e-12 immunological disorder 2.46e-073.66e-13 rheumatoid arthritis 3.78e-072.54e-07 shape change of Epithelial Cells 8.86e-07 alzheimer's disease 3.60e-062.27e-07 parkinson's disease 7.24e-065.29e-06 shape change of Dermal Cells 9.33e-06 Insulin-dependent diabetes mellitus 3.76e-15 neuropathy 5.38e-12 amyotrophic lateral sclerosis 1.36e-09 arthritis 1.44e-07\n\nVitamin D HYPOTHESIS\nan INTERESTING HYPOTHESIS HAS BEEN PROPOSED by mcgrace [28] claiming that low Prenatal Vitamin D increases the risk of a wide range of diseases such as multiple sclerosis, diabetes, schizophrenia, Prostate cancer, Breast cancer and Colorectal cancer because of its versatile function in normal development.""]"	[('INCOMPLETE_EVIDENCE', 1099), ('ANOMALY_CURIOUS_FINDING', 1113), ('INCOMPLETE_EVIDENCE', 1125), ('INCOMPLETE_EVIDENCE', 1136), ('INCOMPLETE_EVIDENCE', 1145)]	5	[('GO_0036367', 'light adaption', 82, 'signaturesCEUYRI'), ('UBERON_0001621', 'coronary artery', 125, 'Coronary artery'), ('SO_0000704', 'gene', 166, 'Genetic'), ('UBERON_0004535', 'cardiovascular system', 200, 'Cardiovascular'), ('PR_000045358', 'insulin family protein', 244, 'insulin'), ('UBERON_0000949', 'endocrine system', 297, 'Endocrine system'), ('UBERON_0001016', 'nervous system', 370, 'Neurological'), ('GO_0008152', 'metabolic process', 485, 'Metabolic'), ('UBERON_0004854', 'gastrointestinal system mesentery', 560, 'Digestive system'), ('UBERON_0004288', 'skeleton', 603, 'Skeletal'), ('UBERON_0005445', 'segment of pes', 697, 'Autoimmune'), ('CL_0000066', 'epithelial cell', 827, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 827, 'epithelial'), ('CL_0000346', 'hair follicle dermal papilla cell', 943, 'dermal cells'), ('PR_000045358', 'insulin family protein', 965, 'Insulin'), ('CHEBI_28384', 'vitamin K', 1089, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1188, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1197, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 1307, 'prostate'), ('UBERON_0000310', 'breast', 1324, 'breast'), ('UBERON_0012652', 'colorectum', 1342, 'colorectal')]
S131-PMC2873552	PMC2873552	4/2010	S131-PMC2873552	"[""second, in addition to mcgrace's list of diseases, Animal MODEL studies and epidemiological surveys have FURTHER LINKED Vitamin D insufficiency to Cardiovascular disease and Inflammatory Bowel disease [17,30,31], as well as abnormal Brain Development [31].""]"	[('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('NCBITaxon_33208', 'Metazoa', 51, 'animal'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 147, 'cardiovascular'), ('UBERON_0001782', 'pigmented layer of retina', 174, 'inflammatory bowel'), ('GO_0007420', 'brain development', 233, 'brain development'), ('UBERON_0000955', 'brain', 233, 'brain')]
S152-PMC3257641	PMC3257641	3/2010	S152-PMC3257641	['the MERIT of achieving a relatively high Vitamin D status (>100 nmol/l) has NOT BEEN FULLY ESTABLISHED, particularly in RELATION to offspring Cardiovascular or atopic disease development.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 120)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 142, 'cardiovascular')]
S155-PMC3347028	PMC3347028	3/2012	S155-PMC3347028	['mcgrath and others continue to investigate WHETHER there are lasting EFFECTS of fetal and early infancy Vitamin D deficiency on later Adult disease processes such as Anatomical changes of the Brain, schizophrenia, multiple sclerosis, certain cancers, Cardiovascular disease, and various other Autoimmune diseases such as diabetes and lupus [106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adult'), ('UBERON_0001062', 'anatomical entity', 166, 'anatomical'), ('UBERON_0000955', 'brain', 192, 'brain'), ('UBERON_0004535', 'cardiovascular system', 251, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 293, 'autoimmune')]
S111-PMC3356951	PMC3356951	4/2012	S111-PMC3356951	['[85]\n\nobesity\nlow concentrations of circulating Vitamin D are common with obesity and MAY represent a POTENTIAL mechanism EXPLAINING the elevated risk of certain cancers and Cardiovascular outcomes.']	[('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 122)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 174, 'cardiovascular')]
S151-PMC3356951	PMC3356951	4/2012	S151-PMC3356951	['primary hyperparathyroidism and vdd NEED treatment with Vitamin D.[103]\n\ncaption (table-wrap): table 2\n\ntreatment and prevention STRATEGIES[103]\n\nnoncalcemic benefits of Vitamin D\nescp RECOMMENDS prescribing Vitamin D supplementation for fall PREVENTION and do not RECOMMEND supplementation beyond RECOMMENDED daily NEEDS for the purpose of preventing Cardiovascular disease or death or improving quality of life.']	[('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 129), ('FUTURE_WORK', 185), ('SUPERFICIAL_RELATIONSHIP', 243), ('FUTURE_WORK', 265), ('FUTURE_WORK', 298), ('IMPORTANT_CONSIDERATION', 316)]	7	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 352, 'cardiovascular')]
S177-PMC3356951	PMC3356951	4/2012	S177-PMC3356951	['MORE RESEARCH is REQUIRED to RECOMMEND screening Individuals who are not AT RISK for deficiency or to prescribe Vitamin D to attain the noncalcemic BENEFIT for Cardiovascular protection.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 17), ('FUTURE_WORK', 29), ('IMPORTANT_CONSIDERATION', 73), ('IMPORTANT_CONSIDERATION', 148)]	5	[('NCBITaxon_1', 'root', 49, 'individuals'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 160, 'cardiovascular')]
S172-PMC3424155	PMC3424155	8/2012	S172-PMC3424155	['Vitamin D deficiency during the third Trimester of Pregnancy in Humans HAS BEEN ASSOCIATED with Cardiovascular disease, diabetes and obesity in offspring[23], which COULD BE LINKED to the POTENTIAL ROLE of Vitamin D in the Regulation Of Adiposity[24],[25].']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 165), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 188), ('SUPERFICIAL_RELATIONSHIP', 198), ('SUPERFICIAL_RELATIONSHIP', 223)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0009294', 'DNA mediated transformation', 38, 'trimester'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 64, 'humans'), ('UBERON_0004535', 'cardiovascular system', 96, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0045752', 'positive regulation of Toll signaling pathway', 223, 'regulation of adiposity')]
S16-PMC3427250	PMC3427250	8/2012	S16-PMC3427250	['adequate Vitamin D intake is ASSOCIATED with a lower risk of cancer[7],[8],[9],[10],[11], Cardiovascular diseases[12], Autoimmune diseases[13], Neurological disorders[14]and diabetes[15].']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 90, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 119, 'autoimmune'), ('UBERON_0001016', 'nervous system', 144, 'neurological')]
S186-PMC3616124	PMC3616124	4/2013	S186-PMC3616124	['first, Cardiovascular disease studies SUGGEST that Vitamin E alone has DIFFERENT EFFECTS from Vitamin C and E combined[18],[19],[27].']	[('INCOMPLETE_EVIDENCE', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('UBERON_0004535', 'cardiovascular system', 7, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 108, 'E')]
S191-PMC3616124	PMC3616124	4/2013	S191-PMC3616124	['in PARTIAL SUPPORT of this HYPOTHESIS, we OBSERVED a 3-fold increase in Preeclampsia risk in hp 2-2 hispanic women receiving Vitamin C and E. the original rct combined Vitamins C and E, an approach used in Cardiovascular disease prevention trials[47],[48],[49]that was successful in SMALL clinical trials.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 283)]	5	[('GO_0007128', 'meiotic prophase I', 72, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 139, 'E'), ('CHEBI_27300', 'vitamin D', 168, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 183, 'E'), ('UBERON_0004535', 'cardiovascular system', 206, 'cardiovascular')]
S196-PMC3616124	PMC3616124	4/2013	S196-PMC3616124	['the MOST EXTENSIVELY STUDIED mechanism by which Vitamin E reduces Cardiovascular disease risk in type 2 diabetes is by preventing the hdl dysfunction caused by cross-linking with glycosylated hemoglobin[28].']	[('INCOMPLETE_EVIDENCE', 4)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin E'), ('UBERON_0004535', 'cardiovascular system', 66, 'cardiovascular')]
S28-PMC3651971	PMC3651971	5/2013	S28-PMC3651971	['the trial was conducted in a chronically undernourished population where supplementation with Vitamin A or Β-Carotene reduced maternal mortality,20biochemical Vitamin A deficiency,21night blindness22and morbidity,23but had no overall effect on infant mortality.24in the long term, at 9–13\u2005years of age, the intervention HAS BEEN SHOWN to have improved Lung size25and innate aspects of Immunity,26but has not affected biomarker risk factors for Cardiovascular diseases.27\n\nmethods\n\nselection and description of sample\nthis study followed a sample of Children Born to women who participated in a cluster-randomised, placebo-controlled trial of Vitamin A or Β-Carotene supplementation before, during and after Pregnancy.']	[('INCOMPLETE_EVIDENCE', 320)]	1	[('CHEBI_27300', 'vitamin D', 94, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 107, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin A'), ('UBERON_0002048', 'lung', 352, 'lung'), ('GO_0007566', 'embryo implantation', 385, 'immunity'), ('UBERON_0004535', 'cardiovascular system', 444, 'cardiovascular'), ('GO_0050890', 'cognition', 549, 'children'), ('GO_0007567', 'parturition', 558, 'born'), ('CHEBI_27300', 'vitamin D', 642, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 655, 'β-carotene'), ('GO_0007565', 'female pregnancy', 707, 'pregnancy')]
S126-PMC3659910	PMC3659910	1/2013	S126-PMC3659910	['Animal MODELS of Vitamin D deficiency HAVE SHOWN just how IMPORTANT adequate nutritional intakes of Vitamin D are to Skeletal, Cardiovascular, and Neurologic Development in experimental Animals.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 58)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0001501', 'skeletal system development', 117, 'skeletal ...'), ('UBERON_0001442', 'skeleton of manus', 117, 'skeletal ...'), ('GO_0002026', 'regulation of the force of heart contraction', 127, 'cardiovascular ...'), ('UBERON_0004535', 'cardiovascular system', 127, 'cardiovascular'), ('GO_0007399', 'nervous system development', 147, 'neurologic development'), ('UBERON_0001016', 'nervous system', 147, 'neurologic'), ('NCBITaxon_33208', 'Metazoa', 186, 'animals')]
S127-PMC3659910	PMC3659910	1/2013	S127-PMC3659910	['[27] weishaar and simpson[28] SHOWED that lengthy periods of Vitamin D deficiency in Rats are ASSOCIATED with PROFOUND changes in Cardiovascular function, including increases in Cardiac and vascular muscle Contractile function.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 94), ('IMPORTANT_CONSIDERATION', 110)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 85, 'rats'), ('UBERON_0004535', 'cardiovascular system', 130, 'cardiovascular'), ('UBERON_0000948', 'heart', 178, 'cardiac'), ('GO_0006936', 'muscle contraction', 206, 'contractile')]
S10-PMC3702245	PMC3702245	6/2013	S10-PMC3702245	['a second hydroxylation takes place in the Kidney, which converts 25(Oh)D to the most biologically active Metabolite, 1,25-Dihydroxyvitamin D, the major classical physiologic function of which is to increase calcium and Phosphorus absorption from the Gut in order to maintain Calcium Homeostasis and promote mineralization of Osteoid bone.9\nalthough the Renal 1-alpha hydroxylase (Cytochrome P450 [Cyp]27B1) enzyme is a MAJOR DETERMINANT of Synthesis of 1,25-Dihydroxyvitamin D, IT IS KNOWN that Cyp27B1 is Expressed in Nonrenal Tissues to produce 1,25 Dihydroxyvitamin D.6,19in addition, Vitamin D receptors are also Expressed in a variety of Organs, Tissues, and cells (seefigure 1).20the 1,25-Dihydroxyvitamin D locally produced in Extrarenal Tissues, such as immune cells, Pancreatic Beta Cells, the Intestine, Prostate, Breast, and other Organs, Controls multiple Vitamin D-responsive Genes, and THUS plays an important physiologic ROLE in Cardiovascular health,21,22the Adaptive and Innate Immune Responses,23,24insulin secretion,25,26regulation of Cell Proliferation, Differentiation, and Apoptosis, and inhibition of Angiogenesis.27\n\nVitamin D Homeostasis and functions during Pregnancy\nthe classical function of Vitamin D is to maintain calcium Homeostasis.']	[('IMPORTANT_CONSIDERATION', 419), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 478), ('PROBABLE_UNDERSTANDING', 900), ('SUPERFICIAL_RELATIONSHIP', 936)]	5	[('UBERON_0002113', 'kidney', 42, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 105, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 117, '1,25-dihydroxyvitamin D'), ('CHEBI_35885', 'secondary phosphine', 219, 'phosphorus'), ('UBERON_0001555', 'digestive tract', 250, 'gut'), ('GO_0055073', 'cadmium ion homeostasis', 275, 'calcium homeostasis'), ('UBERON_0008883', 'osteoid', 325, 'osteoid'), ('UBERON_0002113', 'kidney', 353, 'renal'), ('CHEBI_4056', 'cytochrome', 380, 'cytochrome'), ('PR_000006100', 'aromatase', 380, 'cytochrome P450'), ('PR_000006138', 'cytochrome P450 4F11', 397, 'CYP ... 27B1'), ('GO_0009057', 'macromolecule catabolic process', 440, 'synthesis'), ('CHEBI_67472', '15-epi-lupulin B', 453, '1,25-dihydroxyvitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 495, 'CYP27B1'), ('GO_0010467', 'gene expression', 506, 'expressed'), ('UBERON_0002481', 'bone tissue', 519, 'nonrenal tissues'), ('CHEBI_67469', '15-hydroxyajubractin C', 547, '1,25 dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 588, 'vitamin D'), ('GO_0010467', 'gene expression', 617, 'expressed'), ('UBERON_0000062', 'organ', 643, 'organs'), ('UBERON_0000479', 'tissue', 651, 'tissues'), ('CHEBI_67472', '15-epi-lupulin B', 690, '1,25-dihydroxyvitamin D'), ('UBERON_0005292', 'extraembryonic tissue', 734, 'extrarenal tissues'), ('CL_0000169', 'type B pancreatic cell', 776, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 776, 'pancreatic'), ('UBERON_0000160', 'intestine', 803, 'intestine'), ('UBERON_0002367', 'prostate gland', 814, 'prostate'), ('UBERON_0000310', 'breast', 824, 'breast'), ('UBERON_0000062', 'organ', 842, 'organs'), ('GO_0065007', 'biological regulation', 850, 'controls'), ('CHEBI_27300', 'vitamin D', 868, 'vitamin D'), ('SO_0000704', 'gene', 889, 'genes'), ('UBERON_0004535', 'cardiovascular system', 944, 'cardiovascular'), ('GO_0051886', 'negative regulation of timing of anagen', 975, 'adaptive ...'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 988, 'innate immune responses'), ('UBERON_0002405', 'immune system', 995, 'immune'), ('GO_0030154', 'cell differentiation', 1054, 'cell proliferation ... differentiation'), ('GO_0006915', 'apoptotic process', 1095, 'apoptosis'), ('GO_0001525', 'angiogenesis', 1124, 'angiogenesis'), ('CHEBI_28384', 'vitamin K', 1141, 'Vitamin D'), ('GO_0042592', 'homeostatic process', 1151, 'homeostasis'), ('GO_0007565', 'female pregnancy', 1184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1220, 'vitamin D'), ('GO_0042592', 'homeostatic process', 1253, 'homeostasis')]
S3-PMC3717170	PMC3717170	5/2013	S3-PMC3717170	['THIS REPORT summarizes RECENT RESEARCH on the ROLES for Vitamin D in cancer, Immunity and Autoimmune diseases, Cardiovascular and Respiratory health, Pregnancy, obesity, Erythropoiesis, diabetes, muscle function, and Aging.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007566', 'embryo implantation', 77, 'immunity'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 111, 'cardiovascular'), ('UBERON_0001004', 'respiratory system', 130, 'respiratory'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0030218', 'erythrocyte differentiation', 170, 'erythropoiesis'), ('GO_0007568', 'aging', 217, 'aging')]
S49-PMC3717170	PMC3717170	5/2013	S49-PMC3717170	['Vitamin D in the Heart and Vascular System\ndavid g. gardner (university of california, san francisco) expanded the discussion of nonclassical EFFECTS of Vitamin D to include EVIDENCE of a significant ROLE for Vitamin D in the Cardiovascular System.']	[('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 200)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000948', 'heart', 17, 'heart'), ('UBERON_0007798', 'vascular system', 27, 'vascular system'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 226, 'cardiovascular system')]
S50-PMC3717170	PMC3717170	5/2013	S50-PMC3717170	['WHILE the Heart and Vasculature have ONLY RECENTLY been identified as POTENTIAL targets of Vitamin D action, a GROWING body of EVIDENCE SUGGESTS that the activated vdr plays an IMPORTANT ROLE in Regulating Cardiovascular function.8first, the vdr and the ligand-generating 25-Hydroxyvitamin D31-α-hydroxylase HAVE BEEN SHOWN to be present in Cardiac Myocytes, Cardiac Fibroblasts, Vascular Smooth Muscle Cells, and Vascular Endothelial Cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 136), ('IMPORTANT_CONSIDERATION', 177), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 308)]	9	[('UBERON_0000948', 'heart', 10, 'heart'), ('UBERON_0002049', 'vasculature', 20, 'vasculature'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 195, 'regulating'), ('UBERON_0004535', 'cardiovascular system', 206, 'cardiovascular'), ('CHEBI_67376', 'dihydrooroxylin A', 272, '25-hydroxyvitamin'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 290, 'D31'), ('CL_0000746', 'cardiac muscle cell', 341, 'cardiac myocytes'), ('UBERON_0000948', 'heart', 341, 'cardiac'), ('CL_0002548', 'fibroblast of cardiac tissue', 359, 'cardiac fibroblasts'), ('UBERON_0000948', 'heart', 359, 'cardiac'), ('CL_0000359', 'vascular associated smooth muscle cell', 380, 'vascular smooth muscle cells'), ('UBERON_0001135', 'smooth muscle tissue', 389, 'smooth muscle'), ('CL_0000071', 'blood vessel endothelial cell', 414, 'vascular endothelial cells'), ('UBERON_0001986', 'endothelium', 423, 'endothelial')]
S66-PMC3717170	PMC3717170	5/2013	S66-PMC3717170	['collectively, these data DEMONSTRATE that the Vitamin D system—specifically, the ligand-bound vdr—plays an IMPORTANT ROLE in the maintenance of Cardiovascular health and SUGGEST that Vitamin D repletion MAY have IMPORTANT PUBLIC HEALTH IMPLICATIONS in Controlling the prevalence of, and morbidity ASSOCIATED with, Cardiovascular disease.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('IMPORTANT_CONSIDERATION', 107), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 203), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 222), ('SUPERFICIAL_RELATIONSHIP', 297)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 144, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0065007', 'biological regulation', 252, 'controlling'), ('UBERON_0004535', 'cardiovascular system', 314, 'cardiovascular')]
S21-PMC3827489	PMC3827489	10/2013	S21-PMC3827489	['the wide variety of nonskeletal diseases in which Vitamin D is IMPORTANT include Cardiovascular diseases3), obesity4), Metabolic syndrome5), Insulin resistance6), infection7), allergy8,9), some forms of cancers10-12), and Autoimmune diseases13).']	[('IMPORTANT_CONSIDERATION', 63)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 81, 'cardiovascular'), ('GO_0008152', 'metabolic process', 119, 'metabolic'), ('PR_000045358', 'insulin family protein', 141, 'insulin'), ('UBERON_0001442', 'skeleton of manus', 222, 'autoimmune')]
S9-PMC4113768	PMC4113768	7/2014	S9-PMC4113768	['mega-trials have the POTENTIAL to detect small effect sizes of Vitamin D supplementation on end-points such as incidence and mortality from Cardiovascular disease and cancer.']	[('INCOMPLETE_EVIDENCE', 21)]	1	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 140, 'cardiovascular')]
S668-PMC4113768	PMC4113768	7/2014	S668-PMC4113768	['; dyall, l.; kepa, m.\nbackground: POSSIBLE CONSEQUENCES of low Vitamin D status include osteoporosis, falls, Cardiovascular disease, cancer, and diabetes, all of which are LIKELY to be more SERIOUS for men and women of advanced age (>80 years) compared to younger Adults.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBLEM_COMPLICATION', 43), ('PROBABLE_UNDERSTANDING', 172), ('IMPORTANT_CONSIDERATION', 190)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 109, 'cardiovascular'), ('UBERON_0007023', 'adult organism', 264, 'adults')]
S1077-PMC4113768	PMC4113768	7/2014	S1077-PMC4113768	['higher Serum 25(Oh) Vitamin D levels were CONSISTENTLY FOUND among subjects with no prevalent Cardiovascular risk factors ( p> 0.05) except for those subjects with serum crp level ≥3 mg/l, tc/Hdl-C ratio ≥5, and those with 4 or more Pregnancies.']	[('PROBABLE_UNDERSTANDING', 42), ('INCOMPLETE_EVIDENCE', 55)]	2	[('UBERON_0001977', 'blood serum', 7, 'serum'), ('CHEBI_30778', 'gallic acid', 13, '25(OH)'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 94, 'cardiovascular'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 192, 'HDL-C'), ('GO_0007565', 'female pregnancy', 233, 'pregnancies')]
S1081-PMC4113768	PMC4113768	7/2014	S1081-PMC4113768	['the precise nature of this ASSOCIATION and the optimum levels of Vitamin D for Cardiovascular health remain to be elucidated.']	[('SUPERFICIAL_RELATIONSHIP', 27)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 79, 'cardiovascular')]
S1376-PMC4113768	PMC4113768	7/2014	S1376-PMC4113768	['we AIMED TO EXAMINE the ASSOCIATION between Vitamin D concentration and Insulin resistance in healthy, non-diabetic, overweight Individuals at high risk of Cardiovascular disease using gold-standard techniques for assessment of both Vitamin D concentration and Insulin resistance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 24)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('PR_000045358', 'insulin family protein', 72, 'insulin'), ('NCBITaxon_1', 'root', 128, 'individuals'), ('UBERON_0004535', 'cardiovascular system', 156, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('PR_000045358', 'insulin family protein', 261, 'insulin')]
S1444-PMC4113768	PMC4113768	7/2014	S1444-PMC4113768	['background: epidemiological studies SUGGEST an ASSOCIATION between Vitamin D status and Cardiovascular disease (cvd) RISK.']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 117)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 88, 'cardiovascular')]
S1851-PMC4113768	PMC4113768	7/2014	S1851-PMC4113768	['NUMEROUS STUDIES have REPORTED that Vitamin D deficiency plays a significant ROLE in the Regulation Of Blood Pressure and Cardiovascular health.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0008217', 'regulation of blood pressure', 89, 'regulation of blood pressure'), ('UBERON_0000178', 'blood', 103, 'blood'), ('UBERON_0004535', 'cardiovascular system', 122, 'cardiovascular')]
S2023-PMC4113768	PMC4113768	7/2014	S2023-PMC4113768	['; lanham-new, s.; tripkovic, l.\nbackground: epidemiological research HAS SHOWN a close ASSOCIATION between Vitamin D deficiency (25Ohd < 25 nmol/l) and Cardiovascular mortality and morbidity.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 87)]	2	"[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 129, '25OHD'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular')]"
S2097-PMC4113768	PMC4113768	7/2014	S2097-PMC4113768	['background: ACCUMULATING EVIDENCE SUGGESTS that Vitamin D deficiency MAY BE a risk FACTOR for Cardiovascular disease BUT its ASSOCIATION with the risk of stroke is UNCERTAIN.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('SUPERFICIAL_RELATIONSHIP', 125), ('FULL_UNKNOWN', 164)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 94, 'cardiovascular')]
S2104-PMC4113768	PMC4113768	7/2014	S2104-PMC4113768	['conclusions: low Vitamin D levels were ASSOCIATED with an INCREASED RISK of stroke in this prospective cohort study of older primary care patients.this ASSOCIATION was INDEPENDENT of several IMPORTANT CONFOUNDERS and ONLY PARTLY EXPLAINED by conventional risk factors and Cardiovascular disease AS POTENTIAL causal intermediates.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 191), ('PROBLEM_COMPLICATION', 201), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('PROBABLE_UNDERSTANDING', 295), ('INCOMPLETE_EVIDENCE', 298)]	11	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 272, 'cardiovascular')]
S2272-PMC4113768	PMC4113768	7/2014	S2272-PMC4113768	['background: ACCUMULATING EVIDENCE has stipulated a strong CORRELATION between Vitamin D (vitd) deficiency and Cardiovascular disease (cvd) HOWEVER a mechanistic LINK is missing.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('ANOMALY_CURIOUS_FINDING', 139), ('SUPERFICIAL_RELATIONSHIP', 161)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 110, 'cardiovascular')]
S2662-PMC4113768	PMC4113768	7/2014	S2662-PMC4113768	['there is ACCUMULATING EVIDENCE from meta-analyses of cohort studies that Vitamin D deficiency, AS measured by low Serum levels of 25-Hydroxy Vitamin D (25(Oh)D), PREDICTS INCREASED RISK of all-cause mortality, Cardiovascular disease and hypertension.']	[('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 171)]	4	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001977', 'blood serum', 114, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 130, '25-hydroxy vitamin D'), ('CHEBI_33010', 'chromide(1-)', 154, '(OH)D'), ('UBERON_0004535', 'cardiovascular system', 210, 'cardiovascular')]
S3066-PMC4113768	PMC4113768	7/2014	S3066-PMC4113768	['RISK FACTORS for Cardiovascular disease HAVE also BEEN ASSOCIATED with low Serum (25(Oh)D. we AIMED TO INVESTIGATE WHETHER high-dose Vitamin D supplementation CAN improve Glucose Metabolism in a population with impaired fasting Glucose and/or impaired Glucose tolerance.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 55), ('QUESTION_ANSWERED_BY_THIS_WORK', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 159)]	7	[('UBERON_0004535', 'cardiovascular system', 17, 'cardiovascular'), ('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('CHEBI_17234', 'glucose', 171, 'glucose'), ('GO_0006006', 'glucose metabolic process', 171, 'glucose metabolism'), ('CHEBI_17234', 'glucose', 228, 'glucose'), ('CHEBI_17234', 'glucose', 252, 'glucose')]
S12-PMC4169453	PMC4169453	9/2014	S12-PMC4169453	['trial registration\nclinicaltrials.govnct01506557\n\nintroduction\nGROWING EVIDENCE SUGGESTS that Vitamin D deficiency has a negative IMPACT on the Skeletal System and MAY BE a POTENTIAL RISK FACTOR for a wide range of diseases, including cancer, Cardiovascular disease, hypertension, diabetes, Autoimmune diseases, and allergies[1].']	[('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 183)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001434', 'skeletal system', 144, 'skeletal system'), ('UBERON_0004535', 'cardiovascular system', 243, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 291, 'autoimmune')]
S89-PMC4346113	PMC4346113	3/2015	S89-PMC4346113	['low maternal Protein Consumption or poor Vitamin B and methionine status are ASSOCIATED with behavioral and Cardiovascular abnormalities, and sex-specific changes in Hepatic Gene Expression in Rat fetuses and changes in Imprinted Gene Expression in the Rat Embryo-fetal axis [40,74-76].']	[('SUPERFICIAL_RELATIONSHIP', 77)]	1	[('GO_0006412', 'translation', 13, 'protein consumption'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin B'), ('UBERON_0004535', 'cardiovascular system', 108, 'cardiovascular'), ('UBERON_0002107', 'liver', 166, 'hepatic'), ('GO_0010467', 'gene expression', 174, 'gene expression'), ('SO_0000704', 'gene', 174, 'gene'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 193, 'rat'), ('GO_0071514', 'genetic imprinting', 220, 'imprinted'), ('GO_0010467', 'gene expression', 230, 'gene expression'), ('SO_0000704', 'gene', 230, 'gene'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 253, 'rat'), ('UBERON_0000922', 'embryo', 257, 'embryo')]
S12-PMC4417995	PMC4417995	4/2015	S12-PMC4417995	['the function of Vitamin D, traditionally ASSOCIATED with calcium and Phosphate Homeostasis, IS THOUGHT TO be highly COMPLEX, and its POTENTIAL ROLES in Cardiovascular, neoplastic, and Microbial infections and Autoimmune diseases HAVE BEEN investigated in RECENT STUDIES [5].']	[('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 92), ('DIFFICULT_TASK', 116), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 143), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 255)]	7	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0051320', 'S phase', 69, 'phosphate'), ('GO_0042592', 'homeostatic process', 79, 'homeostasis'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('NCBITaxon_10088', 'Mus <genus>', 184, 'microbial'), ('UBERON_0001442', 'skeleton of manus', 209, 'autoimmune')]
S15-PMC4466139	PMC4466139	6/2015	S15-PMC4466139	['moreover, in RECENT YEARS, Vitamin D deficiency HAS BEEN CONSIDERED AS a POSSIBLE cause of several diseases, including Microbial infections, Cardiovascular and allergic diseases, cancers, type 1 diabetes, multiple sclerosis and other Autoimmune diseases [1–10].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 73)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 119, 'microbial'), ('UBERON_0004535', 'cardiovascular system', 141, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 234, 'autoimmune')]
S13-PMC4516377	PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
S59-PMC4598849	PMC4598849	10/2015	S59-PMC4598849	['the FINDING that Vitamin D levels in the upper range increased the health RISK in THIS STUDY was CONSISTENT with PREVIOUS STUDIES examining the risk of fetal growth restriction11, Allergic Response3031, lower-extremity function32, frailty status33, as well as Cardiovascular disease3435.']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 74), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0019267', 'asparagine biosynthetic process from cysteine', 180, 'allergic response3031'), ('UBERON_0004535', 'cardiovascular system', 260, 'cardiovascular')]
S16-PMC4600246	PMC4600246	10/2015	S16-PMC4600246	['this was NOT SHOWN with vitamin k1intake (Phylloquinone, the major dietary source of Vitamin K.2627thus, dietary vitamin k1intake, without Vitamin K2, MAY not be sufficient to suppress Arterial calcifications and/or reduce RISK for subsequent Cardiovascular events and death.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 151), ('IMPORTANT_CONSIDERATION', 223)]	3	[('CHEBI_26124', 'phytosteroid', 42, 'phylloquinone'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin K'), ('CHEBI_28934', 'vitamin D2', 139, 'vitamin K2'), ('UBERON_0001637', 'artery', 185, 'arterial'), ('UBERON_0004535', 'cardiovascular system', 243, 'cardiovascular')]
S14-PMC4829940	PMC4829940	5/2016	S14-PMC4829940	['low 25(Oh)D levels HAVE BEEN ASSOCIATED with a range of adverse conditions, from Pregnancy outcomes to childhood illnesses and chronic disease including osteoporosis, cancer and Cardiovascular disease in Adulthood[3], ALTHOUGH randomized controlled trials of Vitamin D supplements do NOT SUPPORT causality for Extra-Skeletal outcomes[4],[5].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 29), ('ANOMALY_CURIOUS_FINDING', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 284)]	4	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 4, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('UBERON_0004535', 'cardiovascular system', 178, 'cardiovascular'), ('UBERON_0000113', 'post-juvenile adult stage', 204, 'adulthood'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 310, 'extra-skeletal')]
S10-PMC4934634	PMC4934634	11/2015	S10-PMC4934634	['over the past two decades, it HAS BEEN WELL ACCEPTED that Vitamin D is a pro-hormone, and suboptimal Vitamin D status HAS been increasingly LINKED to a broad range of diseases including, cancer, diabetes, Cardiovascular disease, and Autoimmune disorders.']	[('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 39), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 140)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 205, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 233, 'autoimmune')]
S15-PMC4944244	PMC4944244	7/2016	S15-PMC4944244	['lack of Vitamin D MAY have an adverse health EFFECTS including death, cancer, Cardiovascular disease, impaired Immune function and Glucose Metabolism [4].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 78, 'cardiovascular'), ('UBERON_0002405', 'immune system', 111, 'immune'), ('CHEBI_17234', 'glucose', 131, 'glucose'), ('GO_0006006', 'glucose metabolic process', 131, 'glucose metabolism')]
S69-PMC5014971	PMC5014971	8/2016	S69-PMC5014971	['respondents were CONCERNED about Vitamin D deficiency and osteoporosis (91.1%) and bone fractures (88.1%), but less CONCERNED about other POSSIBLE sequelae of Vitamin D deficiency such as a weakened Immune System (32.7%), Colon cancer (27.7%), Cardiovascular disease (23.8%), impaired glucose Metabolism (22.8%), vulnerability to preeclampsia (22.8%), increased risk of small-for-Gestational-age infant (21.8%), vulnerability to Preterm Labor (19.8%), Breast cancer (14.9%), hypertension (12.9%), and infertility (10.9%).']	[('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 116), ('INCOMPLETE_EVIDENCE', 138)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('UBERON_0002405', 'immune system', 199, 'immune system'), ('UBERON_0001155', 'colon', 222, 'colon'), ('UBERON_0004535', 'cardiovascular system', 244, 'cardiovascular'), ('GO_0008152', 'metabolic process', 293, 'metabolism'), ('GO_0007565', 'female pregnancy', 380, 'gestational'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 429, 'preterm labor'), ('UBERON_0000310', 'breast', 452, 'breast')]
S17-PMC5051327	PMC5051327	9/2016	S17-PMC5051327	['introduction\nVitamin D is NECESSARY for optimal Skeletal function and deficiency is RELATED to rachitis.1\nit is, HOWEVER, IMPORTANT for bone Metabolism, as well as for optimal function of Striated and Smooth Muscle strength including Heart Muscle, and is RELATED to Postnatal muscle strength.2vitamin D supplementation has a positive IMPACT on muscle strength on Individuals with Vitamin D deficiency.134THE institute of medicine (iom), usa RECOMMENDS daily nutritional intake of Vitamin D of 600\u2005u, BUT OTHERS RECOMMEND higher doses.56a RECENT swedish STUDY SHOWED that the mean nutritional intake of Vitamin D was <200\u2005u/day.7ALTHOUGH Vitamin D is found in low amounts in the diet, mainly in oily fish and egg, the primary source of Vitamin D for Humans is skin conversion to Vitamin D from solar ultraviolet radiation.1pregnant women residing at high latitudes are AT RISK of Vitamin D deficiency BECAUSE of low solar intensity, especially during the winter months.18vitamin D deficiency is common in the nordic countries, ESPECIALLY among those not exposing themselves to the sun.8since fetal Vitamin D levels are directly RELATED to that of their mothers there is also a high LIKELIHOOD of fetal Vitamin D deficiency in our population.9\nBirth asphyxia is ASSOCIATED with Cardiovascular dysfunction, including low Ventricular output, lower left Ventricular Ejection fraction and increased troponin levels.1011congestive Heart failure MAY occur in severe cases of asphyxia.12intrauterine fetal distress is RELATED to an increase in Blood pressure, redistribution and a change in fetal Heart rate pattern.']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('IMPORTANT_CONSIDERATION', 122), ('SUPERFICIAL_RELATIONSHIP', 255), ('SUPERFICIAL_RELATIONSHIP', 334), ('INCOMPLETE_EVIDENCE', 401), ('FUTURE_WORK', 441), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504), ('FUTURE_WORK', 511), ('INCOMPLETE_EVIDENCE', 538), ('INCOMPLETE_EVIDENCE', 559), ('ANOMALY_CURIOUS_FINDING', 627), ('IMPORTANT_CONSIDERATION', 868), ('PROBABLE_UNDERSTANDING', 900), ('ANOMALY_CURIOUS_FINDING', 1026), ('SUPERFICIAL_RELATIONSHIP', 1127), ('PROBABLE_UNDERSTANDING', 1181), ('SUPERFICIAL_RELATIONSHIP', 1260), ('INCOMPLETE_EVIDENCE', 1438), ('SUPERFICIAL_RELATIONSHIP', 1509)]	22	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0004288', 'skeleton', 48, 'skeletal'), ('GO_0008152', 'metabolic process', 141, 'metabolism'), ('UBERON_0002435', 'striatum', 188, 'striated'), ('UBERON_0001135', 'smooth muscle tissue', 201, 'smooth muscle'), ('UBERON_0001133', 'cardiac muscle tissue', 234, 'heart muscle'), ('GO_0007567', 'parturition', 266, 'postnatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 301, 'D'), ('NCBITaxon_1', 'root', 363, 'individuals'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 480, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 637, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 735, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'humans'), ('CHEBI_27300', 'vitamin D', 778, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 879, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 978, 'D'), ('CHEBI_27300', 'vitamin D', 1097, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1201, 'vitamin D'), ('GO_0007567', 'parturition', 1242, 'Birth'), ('UBERON_0004535', 'cardiovascular system', 1276, 'cardiovascular'), ('UBERON_0002082', 'cardiac ventricle', 1318, 'ventricular'), ('UBERON_0002082', 'cardiac ventricle', 1349, 'ventricular'), ('UBERON_0000970', 'eye', 1361, 'ejection'), ('UBERON_0000948', 'heart', 1424, 'heart'), ('UBERON_0000178', 'blood', 1535, 'blood'), ('UBERON_0000948', 'heart', 1588, 'heart')]
S16-PMC5085625	PMC5085625	9/2016	S16-PMC5085625	['the active form of Vitamin D, i.e., 1,25(Oh)2D, is now recognized as an IMPORTANT hormone playing a CRUCIAL role in Skeletal Homeostasis (classical effects) and exerting NON-CLASSICAL EFFECTS in various pathological and physiological conditions, such as cancer, Arterial hypertension, Cardiovascular diseases, Brain Development and Immunomodulation [3,4,5,6].']	[('IMPORTANT_CONSIDERATION', 72), ('IMPORTANT_CONSIDERATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	"[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 38, '25(OH)2D'), ('GO_0043276', 'anoikis', 116, 'skeletal homeostasis'), ('UBERON_0004288', 'skeleton', 116, 'skeletal'), ('UBERON_0001637', 'artery', 262, 'arterial'), ('UBERON_0004535', 'cardiovascular system', 285, 'cardiovascular'), ('GO_0007420', 'brain development', 310, 'brain development'), ('UBERON_0000955', 'brain', 310, 'brain'), ('GO_0050900', 'leukocyte migration', 332, 'immunomodulation')]"
S4-PMC5129897	PMC5129897	10/2016	S4-PMC5129897	['we used 25(Oh)D concentration–health outcome RELATIONS for Breast cancer and Cardiovascular disease and results of clinical trials with Vitamin D for Respiratory infections and Musculoskeletal disorders to ESTIMATE the reductions in disease BURDEN for increased 25(Oh)D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 206), ('IMPORTANT_CONSIDERATION', 241)]	3	[('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 14, 'D'), ('UBERON_0000310', 'breast', 59, 'breast'), ('UBERON_0004535', 'cardiovascular system', 77, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 150, 'respiratory'), ('UBERON_0002204', 'musculoskeletal system', 177, 'musculoskeletal'), ('CHEBI_71657', 'versiconol acetate', 262, '25(OH)D')]
S8-PMC5129897	PMC5129897	10/2016	S8-PMC5129897	['introduction\nduring the past 15\xa0years, CONSIDERABLE INTEREST in the health BENEFITS of Vitamin D has emerged BECAUSE People with higher ultraviolet-b (uvb) exposure and/or 25-Hydroxyvitamin D [25(Oh)D] concentrations have lower RISK of many diseases and conditions.1our analysis is LIMITED to the diseases with the greatest economic EFFECT and the STRONGEST evidence of PROTECTIVE ROLES of Vitamin D—namely, cancer, Cardiovascular disease (cvd), dementia, diabetes mellitus (dm), falls and fractures, multiple sclerosis (ms), and Respiratory Tract infections.']	[('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 75), ('PROBABLE_UNDERSTANDING', 109), ('IMPORTANT_CONSIDERATION', 228), ('INCOMPLETE_EVIDENCE', 282), ('SUPERFICIAL_RELATIONSHIP', 333), ('INCOMPLETE_EVIDENCE', 348), ('SUPERFICIAL_RELATIONSHIP', 370), ('SUPERFICIAL_RELATIONSHIP', 381)]	11	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'people'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 172, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 390, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 416, 'cardiovascular'), ('UBERON_0000065', 'respiratory tract', 530, 'respiratory tract')]
S22-PMC5129897	PMC5129897	10/2016	S22-PMC5129897	['diseases included in THIS STUDY along with a brief overview of the mechanisms of Vitamin D for each disease and a listing of a few observational studies and clinical trials in support.diseasemechanismsobservational studiesclinical trialscancereffects on cells, Angiogenesis, and metastasis10breast and Colorectal cancer incidence11; survival12breast and all-cancer incidence13cvdeffects on Serum Cholesterol levels, Arterial stiffness, Insulin resistance, hyperglycemia, and increased incident Metabolic syndrome are POTENTIALLY PLAUSIBLE mediators8refs.14,15effect on cvd risk factors16dementiaregulation of Calcium Homeostasis, clearance of Amyloid-Β peptide, antioxidant and anti-inflammatory EFFECTS, and POSSIBLE protection against the neurodegenerative mechanisms ASSOCIATED with ad17incidence18\xa0dmimproves Insulin sensitivity and secretion, mainly via its anti-inflammatory properties19incidence20; meta-analysis21\xa0falls and fracturesreduces bone mass loss by reducing inflammation22; maintains cognition23; helps maintain muscle mass24ref.25ref.26mseffects on Regulatory T and B Cells27Ref.28\xa0respiratory infectionsinduction of Cathelicidin and defensins29; strengthens Adaptive and innate Immune System30Pneumonia31Influenza32,33; ari34\nad, alzheimer disease; ari, acute Respiratory Tract infection; cvd, Cardiovascular disease; dm, diabetes mellitus; ms, multiple sclerosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 517), ('INCOMPLETE_EVIDENCE', 529), ('SUPERFICIAL_RELATIONSHIP', 696), ('INCOMPLETE_EVIDENCE', 709), ('SUPERFICIAL_RELATIONSHIP', 770)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0001525', 'angiogenesis', 261, 'angiogenesis'), ('UBERON_0012652', 'colorectum', 302, 'colorectal'), ('UBERON_0001977', 'blood serum', 390, 'serum'), ('CHEBI_16113', 'cholesterol', 396, 'cholesterol'), ('UBERON_0001637', 'artery', 416, 'arterial'), ('PR_000045358', 'insulin family protein', 436, 'insulin'), ('GO_0008152', 'metabolic process', 494, 'metabolic'), ('GO_0055073', 'cadmium ion homeostasis', 609, 'calcium homeostasis'), ('PR_000004519', 'autism susceptibility gene 2 protein', 643, 'amyloid-β'), ('PR_000045358', 'insulin family protein', 813, 'insulin'), ('CL_0000815', 'regulatory T cell', 1068, 'regulatory T ...'), ('GO_0065007', 'biological regulation', 1068, 'regulatory'), ('CL_0000960', 'T3 B cell', 1085, 'B cells27Ref'), ('PR_000006009', 'alpha-catulin', 1136, 'cathelicidin'), ('GO_0051886', 'negative regulation of timing of anagen', 1178, 'adaptive ...'), ('UBERON_0003822', 'forelimb stylopod', 1198, 'immune system30Pneumonia31Influenza32'), ('UBERON_0000065', 'respiratory tract', 1280, 'respiratory tract'), ('UBERON_0004535', 'cardiovascular system', 1314, 'cardiovascular')]
S27-PMC5129897	PMC5129897	10/2016	S27-PMC5129897	['materials and methods\npublications on the RELATIONS between 25(Oh)D concentrations and health outcomes were obtained LARGELY by searchingpubmed.govandscholar.google.comfor terms such as Vitamin D, 25-Hydroxyvitamin D, meta-analysis, Back and Spine disorders, cancer, Cardiovascular disease, Immune System, osteoporosis, Respiratory infection, economic BURDEN, canada, cost, season, mortality, incidence , and risk .']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 352)]	3	[('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 60, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 197, '25-hydroxyvitamin D'), ('UBERON_0001137', 'dorsum', 233, 'back'), ('UBERON_0001013', 'adipose tissue', 242, 'spine'), ('UBERON_0004535', 'cardiovascular system', 267, 'cardiovascular'), ('UBERON_0002405', 'immune system', 291, 'immune system'), ('UBERON_0001004', 'respiratory system', 320, 'respiratory')]
S13-PMC5340372	PMC5340372	3/2017	S13-PMC5340372	['since the discovery that MOST Tissues and cells have Vitamin D receptors, there has been great INTEREST in its ROLE in the development of many diseases, such as cancer [1], Cardiovascular diseases [2], infectious diseases [3], and Autoimmune disease [4].']	[('PROBABLE_UNDERSTANDING', 25), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('UBERON_0000479', 'tissue', 30, 'tissues'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 173, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 231, 'autoimmune')]
S6-PMC5405075	PMC5405075	4/2017	S6-PMC5405075	['introduction\nepidemiological and experimental data on health IMPACT of “Multitasking” Vitamin D SUPPORT a PROTECTIVE EFFECT of Vitamin D over diseases such as cancer, Cardiovascular, Autoimmune, dementia, and diabetes (1,2).']	[('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('GO_0007618', 'mating', 72, 'multitasking'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 167, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 183, 'autoimmune')]
S17-PMC5474873	PMC5474873	6/2017	S17-PMC5474873	['EVIDENCE now LINKS low Vitamin D levels with reduced Cognitive performance (8), INCREASED RISK for cancer, diabetes, Cardiovascular disease, and premature death (9,10).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 80)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0050890', 'cognition', 53, 'cognitive'), ('UBERON_0004535', 'cardiovascular system', 117, 'cardiovascular')]
S0-PMC5685050	PMC5685050	10/2014	S0-PMC5685050	['vitamin D deficiency in thailand☆\nvitamin D deficiency has received INCREASED ATTENTION over the past several years since Vitamin D MAY play an IMPORTANT ROLE not ONLY in bone Metabolism but also in a variety of non-Skeletal diseases such as diabetes mellitus, Autoimmune diseases, infectious diseases, Cardiovascular diseases and cancer1,2,3.']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 132), ('IMPORTANT_CONSIDERATION', 144), ('SUPERFICIAL_RELATIONSHIP', 154), ('INCOMPLETE_EVIDENCE', 163)]	5	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 8, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 42, 'D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0008152', 'metabolic process', 176, 'metabolism'), ('UBERON_0004288', 'skeleton', 216, 'skeletal'), ('UBERON_0001442', 'skeleton of manus', 261, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 303, 'cardiovascular')]
S18-PMC5706533	PMC5706533	11/2017	S18-PMC5706533	['beyond its established INFLUENCE on bone growth and Calcium Homeostasis,1vitamin D and its RELATED Metabolites have HYPOTHESISED EFFECTS on the risk of Cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions RELATED to Pregnancy (such as pre-eclampsia, Gestational diabetes), and Birth outcomes.6concern that Vitamin D deficiency is a global PUBLIC HEALTH PROBLEM HAS BEEN sparked by numerous REPORTS of the high proportion of Individuals in studies throughout the world who have relatively low Serum/Plasma concentrations of 25-hydroxyvitamin d (25(Oh)D),7the conventional circulating BIOMARKER of Vitamin D status.8there HAS BEEN particular ATTENTION to the high prevalence of vitamin d deficiency in Pregnant women and newborns.7\nin 2010, dietary reference intakes for Vitamin D for canada and the us from the institute of medicine were based solely on bone health—particularly in young children (for instance, rickets) and older Adults (for instance, osteoporosis).1considerable SKEPTICISM was cast onto the LINK between Vitamin D and Extraskeletal health conditions or the POTENTIAL benefits (versus risks) of intakes larger than the recommended dietary allowance (600 iu/day for MOST children and Adults).1THE institute’s report DID NOT RECOMMEND higher intakes during Pregnancy and Lactation.1a 2016 update of the cochrane collaboration systematic review and meta-analysis of trials of Vitamin D in Pregnancy (versus placebo or no Supplement), HOWEVER, TENTATIVELY CONCLUDED that Prenatal Vitamin D supplementation “MAY reduce the risk of pre-eclampsia, low birthweight and Preterm Birth.”6other RECENT systematic reviews that included trials with active control arms (in which participants received Vitamin D) ACKNOWLEDGED the POTENTIAL EFFECT of Vitamin D on fetal growth910but DID NOT FIND evidence of EFFECTS on OTHER maternal, fetal, or infant outcomes.91011citing the 2016 cochrane review,6the world health organization guidelines for Antenatal care ADVISE against routine Vitamin D supplementation in Pregnancy.12dietary and supplementation RECOMMENDATIONS, HOWEVER, vary widely across other professional organisations (appendix 1), and there REMAINS a LACK OF CONSENSUS on target health outcomes, indications for Prenatal supplementation, or EVIDENCE BASED regimens for supplement dose (or fortification STRATEGIES).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 129), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 362), ('IMPORTANT_CONSIDERATION', 376), ('PROBLEM_COMPLICATION', 376), ('INCOMPLETE_EVIDENCE', 384), ('INCOMPLETE_EVIDENCE', 413), ('SUPERFICIAL_RELATIONSHIP', 606), ('INCOMPLETE_EVIDENCE', 643), ('IMPORTANT_CONSIDERATION', 663), ('INCOMPLETE_EVIDENCE', 663), ('IMPORTANT_CONSIDERATION', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1098), ('PROBABLE_UNDERSTANDING', 1205), ('INCOMPLETE_EVIDENCE', 1231), ('INCOMPLETE_EVIDENCE', 1255), ('FUTURE_WORK', 1263), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1471), ('INCOMPLETE_EVIDENCE', 1480), ('INCOMPLETE_EVIDENCE', 1492), ('INCOMPLETE_EVIDENCE', 1543), ('INCOMPLETE_EVIDENCE', 1623), ('INCOMPLETE_EVIDENCE', 1738), ('PROBABLE_UNDERSTANDING', 1738), ('INCOMPLETE_EVIDENCE', 1755), ('SUPERFICIAL_RELATIONSHIP', 1765), ('INCOMPLETE_EVIDENCE', 1807), ('SUPERFICIAL_RELATIONSHIP', 1832), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1843), ('FUTURE_WORK', 1983), ('FUTURE_WORK', 2075), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2092), ('ANOMALY_CURIOUS_FINDING', 2092), ('INCOMPLETE_EVIDENCE', 2177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2187), ('INCOMPLETE_EVIDENCE', 2187), ('INCOMPLETE_EVIDENCE', 2277), ('FUTURE_WORK', 2339)]	42	[('GO_0055073', 'cadmium ion homeostasis', 52, 'calcium homeostasis'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 81, 'D'), ('CHEBI_25212', 'metabolite', 99, 'metabolites'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'gestational'), ('GO_0007567', 'parturition', 300, 'birth'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('NCBITaxon_1', 'root', 447, 'individuals'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('UBERON_0001969', 'blood plasma', 521, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('GO_0007565', 'female pregnancy', 723, 'pregnant'), ('CHEBI_27300', 'vitamin D', 792, 'vitamin D'), ('UBERON_0007023', 'adult organism', 953, 'adults'), ('CHEBI_27300', 'vitamin D', 1045, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 1059, 'extraskeletal'), ('UBERON_0007023', 'adult organism', 1223, 'adults'), ('GO_0007565', 'female pregnancy', 1295, 'pregnancy'), ('GO_0007595', 'lactation', 1309, 'lactation'), ('CHEBI_27300', 'vitamin D', 1413, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1426, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 1458, 'supplement'), ('GO_0007565', 'female pregnancy', 1507, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1516, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1601, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 1727, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1775, 'vitamin D'), ('GO_0007567', 'parturition', 1968, 'antenatal'), ('CHEBI_27300', 'vitamin D', 2006, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2035, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2248, 'prenatal')]
